DailyDoctor Archive Specialties Get app
All anaesthesiology briefings

The edition · Anaesthesiology

Daily sedation interruption probably lowers ICU mortality, updated Cochrane review finds

Twenty-three trials link a daily sedation hold to shorter ventilation and fewer tracheostomies, cannabis users needed only slightly more propofol, and Baxter's premixed dexmedetomidine bags are under a Class II recall.

The edition in brief

An updated Cochrane review of 23 randomised trials in nearly 6,000 ventilated adults and children found daily sedation interruption probably reduced mortality (RR 0.88, 95% CI 0.77 to 0.99; moderate certainty), ICU stay by about 11% and tracheostomy (RR 0.68), and may shorten ventilation by about 14%, with no clear increase in accidental extubation. A Boston cohort of 341,199 anaesthetics found cannabis use was associated with higher propofol and volatile requirements, but the differences were small (about 7 micrograms per kg per minute of propofol for non-medical users and 0.01 to 0.02 MAC). A secondary analysis of a randomised trial in head and neck free-flap surgery found intraoperative dexmedetomidine at 0.3 micrograms per kg per hour was associated with less delirium in the first five days (14.9% vs 34.7%). The FDA lists a Class II recall of Baxter's premixed dexmedetomidine 400 micrograms in 100 mL bags for manufacturing-practice deviations. The pearl: know the lipid emulsion dose for local anaesthetic toxicity before you need it.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free